Ailanthone induces apoptosis in U-2OS cells through the endoplasmic reticulum stress

Yue Zhang1, Taiding Wu2, Chang Li1

  • 1Department of Cardiology, Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China.

Frontiers in Immunology
|October 20, 2025
PubMed
Abstract

Insights

Ailanthone (AIL) effectively inhibits osteosarcoma cell growth and migration by inducing apoptosis through the endoplasmic reticulum stress (ERS) pathway. This natural compound shows promise as a potential therapeutic agent for osteosarcoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteosarcoma (OS) is a prevalent bone cancer in children and adolescents with poor prognoses, necessitating novel therapeutic strategies.
  • Endoplasmic reticulum stress (ERS) and the unfolded protein response (UPR) are critical cellular mechanisms involved in tumor cell apoptosis.
  • Ailanthone (AIL), a natural compound, demonstrates anticancer properties by modulating ERS-related proteins.

Purpose of the Study:

  • To investigate the potential of Ailanthone (AIL) in inducing apoptosis in osteosarcoma (OS) cells via the endoplasmic reticulum stress (ERS) pathway.
  • To evaluate the effects of AIL on OS cell proliferation, migration, and apoptosis.
  • To elucidate the molecular mechanisms underlying AIL's antitumor activity in OS.

Main Methods:

  • Cell counting kit-8 and scratch wound healing assays were used to assess the effects of AIL on U-2OS cell proliferation and migration.
  • Western blot analysis was employed to measure ERS-related and apoptosis-associated protein levels following AIL treatment.
  • Flow cytometry was utilized to quantify the apoptosis rate in AIL-treated U-2OS cells.

Main Results:

  • Ailanthone (AIL) demonstrated a dose- and time-dependent inhibition of U-2OS cell proliferation and migration.
  • AIL treatment significantly increased apoptosis rates in osteosarcoma cells.
  • Western blot analysis revealed increased levels of ERS-related proteins and pro-apoptotic factors, alongside decreased levels of anti-apoptotic proteins.

Conclusions:

  • Ailanthone (AIL) effectively inhibits osteosarcoma cell proliferation and induces apoptosis through the endoplasmic reticulum stress (ERS) pathway.
  • AIL exhibits potential as a therapeutic agent for osteosarcoma treatment.
  • The findings support AIL's role in modulating ERS to achieve antitumor effects in osteosarcoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K